Highlights
Your tasks are as follow:
1. Please, design primers for Sanger sequencing to verify the correct sequence (sequencing in both directions) of the CHRAC1-EGFP fusion cDNA in your expression vector. Remember, that a stretch of quality Sanger sequence is only ~ 300 bp and that good sequence only appears ~ 50 bp downstream of the primer. List the primers so they can be ordered from a company. You do not need to verify the sequence of the expression vector backbone itself, only CHRAC1-EGFP and the sequence where it is integrated in the vector.
2. Please, show that your construct is expressed as a fusion protein without disruption of the EGFP reading frame (e.g., show the nucleotide sequence of the transition from CHRAC1 to EGFP and how this would be translated, e.g. 30 nucleotides up- and downstream of the transition point and the translation into protein).
3. Devise a strategy to transfect your expression construct into human cells. Outline the protocol that you would use and justify the choice of the method and protocol.
This (BS934) Medical Science Assignment has been solved by our Medical Science experts at My Uni Paper. Our Assignment Writing Experts are efficient to provide a fresh solution to this question. We are serving more than 10000+ Students in Australia, UK & US by helping them to score HD in their academics. Our Experts are well trained to follow all marking rubrics & referencing style.
Be it a used or new solution, the quality of the work submitted by our assignment experts remains unhampered. You may continue to expect the same or even better quality with the used and new assignment solution files respectively. There’s one thing to be noticed that you could choose one between the two and acquire an HD either way. You could choose a new assignment solution file to get yourself an exclusive, plagiarism (with free Turnitin file), expert quality assignment or order an old solution file that was considered worthy of the highest distinction.
© Copyright 2026 My Uni Papers – Student Hustle Made Hassle Free. All rights reserved.